Skip to content

Hyperthermy Endocavitary Treatment in Pelvic Pain

Endocavitary Radiofrequency Treatment in Patients Who Present With Chronic Pelvic Pain Compared to Usual Drug Therapy

Status
UNKNOWN
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02837588
Enrollment
60
Registered
2016-07-19
Start date
2015-08-31
Completion date
2016-12-31
Last updated
2016-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Pain

Keywords

chronic pelvic pain, trigger points, hiperthermy

Brief summary

* Treatment at pelvic floor with hyperactivity with hyperthermy electrode MJS * MJS electrode is effective for transvaginal treatment at pelvic pain patients * Hyperthermy treatment with MJS electrode is more effective to usual drugs treatment

Detailed description

This study analyzed the evolution of chronic pelvic pain, defined by the different map of myofascial trigger points assets presents the patient with medical treatment compared to treatment with radiofrequency endocavitary electrode MJS. The initial evaluator analyzed by the NIH-CPSI Scale questionnaire and symptoms of chronic pelvic pain Stanford Protocol for female or male quality of life of the patient before the doctor or radio frequency and a month since treatment. the patient to the Principal Investigator, specialist physiotherapist, who appreciates tenderness the presence of a taut band with a map of pain in endopelvic and exopelvic muscles, determining the activation of myofascial trigger points in each is derived. The Principal Investigator proceeds to address each active myofascial trigger points with the MJS electrode four 20-minute sessions twice a week. The MJS has a curved end pressure which favors the compression point plus the location and accurate approach Radiofrequency pathological point as outstanding feature. The high specificity of myofascial treatment offered by the MJS electrode involves no danger, besides having the computer screen conductivity meter and a temperature sensor on the head to control both parameters in real time during the treatment session

Interventions

DEVICEHyperthermy treatment with MJS electrode

30 patients who are diagnosed Pelvic pain with myofascial syndrome by gyneacologist or urologist goes to Pelvic Floor Physiotherapist for 4 session with hyperthermy treatment with MJS electrode at pelvic floor trigger points

Sponsors

Hospital Universitario Virgen de la Victoria
CollaboratorOTHER
Universidad Rey Juan Carlos
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Women with chronic pelvic pain

Exclusion criteria

* chronic pelvic pain or neurological degenerative etiology * Presence of pathology or infectious processes genitourinary level * possibility of pregnancy or lactating. * Lack of informed consent, mental disorders, dementia, dependent people who need tutor.

Design outcomes

Primary

MeasureTime frameDescription
NIH-CPSI questionnairefour weeksquestions for pelvic pain evaluation

Secondary

MeasureTime frame
pain measure questionnairefour weeks

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026